Development in malarial vaccine: A review.

Meenakshi Dhanawat,N. Das,R. C. Nagarwal,J. Pandit

Published 2010 in Drug Discoveries & Therapeutics

ABSTRACT

No abstract is available for this paper.

PUBLICATION RECORD

Publication year
2010
Venue
Drug Discoveries & Therapeutics
Publication date
2010-10-01
Fields of study
Biology, Medicine
Identifiers
PMID 22491233
External record
Open on Semantic Scholar
Source metadata
Semantic Scholar, PubMed

CITATION MAP

EXTRACTION MAP

CLAIMS

No claims are published for this paper.

CONCEPTS

No concepts are published for this paper.

REFERENCES

Correction: Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
2011cited by this paper
Flow cytometry and the future of vaccine development
2009cited by this paper
The N-terminal domain of Plasmodium falciparum circumsporozoite protein represents a target of protective immunity.
2009cited by this paper
Solid-phase synthesis of oligosaccharide drugs: a review.
2009cited by this paper
Malaria parasite proteins that remodel the host erythrocyte
2009cited by this paper
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial
2009cited by this paper
Potency assays for novel T-cell-inducing vaccines against malaria.
2009cited by this paper
MIG (CXCL9) is a more sensitive measure than IFN-γ of vaccine induced T-cell responses in volunteers receiving investigated malaria vaccines
2009cited by this paper
A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali.
2009cited by this paper
Clinical malaria vaccine development.
2009cited by this paper
Emerging Rules for Subunit‐Based Multiantigenic, Multistage Chemically Synthesized Vaccines
2008cited by this paper
Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.
2008cited by this paper
Phase I Trial of an Alhydrogel Adjuvanted Hepatitis B Core Virus-Like Particle Containing Epitopes of Plasmodium falciparum Circumsporozoite Protein
2008cited by this paper
Malaria vaccines and their potential role in the elimination of malaria
2008cited by this paper
Evidence of Blood Stage Efficacy with a Virosomal Malaria Vaccine in a Phase IIa Clinical Trial
2008cited by this paper
MalVac: Database of malarial vaccine candidates
2008cited by this paper
Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.
2008cited by this paper
Phase 1 Trial of AMA1-C1/Alhydrogel plus CPG 7909: An Asexual Blood-Stage Vaccine for Plasmodium falciparum Malaria
2008cited by this paper
Various carrier system(s)- mediated genetic vaccination strategies against malaria - Retracted
2008cited by this paper
Structural and immunological analysis of circumsporozoite protein peptides: a further step in the identification of potential components of a minimal subunit-based, chemically synthesised antimalarial vaccine.
2008cited by this paper
A phase 1 trial of PfCP2.9: an AMA1/MSP1 chimeric recombinant protein vaccine for Plasmodium falciparum malaria.
2008cited by this paper
Phase 1 Trial of Malaria Transmission Blocking Vaccine Candidates Pfs25 and Pvs25 Formulated with Montanide ISA 51
2008cited by this paper
Safety and Immunogenicity of a Malaria Vaccine, Plasmodium falciparum AMA-1/MSP-1 Chimeric Protein Formulated in Montanide ISA 720 in Healthy Adults
2008cited by this paper
Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants.
2008cited by this paper
Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1
2008cited by this paper
Pre-erythrocytic stage malaria vaccines: time for a change in path.
2007cited by this paper
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
2007cited by this paper
Plasmodium vivax thrombospondin related adhesion protein: immunogenicity and protective efficacy in rodents and Aotus monkeys.
2007cited by this paper
Immunogenicity of a recombinant malaria vaccine based on receptor binding domain of Plasmodium falciparum EBA-175.
2007cited by this paper
Malaria: mechanisms of erythrocytic infection and pathological correlates of severe disease.
2007cited by this paper
Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial.
2007cited by this paper
Design and synthesis of potent antimalarial agents based on clotrimazole scaffold: exploring an innovative pharmacophore.
2007cited by this paper
Pre-erythrocytic malaria vaccines: towards greater efficacy
2006cited by this paper
A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CS.
2006cited by this paper
Disguising itself--insights into Plasmodium falciparum binding and immune evasion from the DBL crystal structure.
2006cited by this paper
Murine Immune Responses to Liver-Stage Antigen 1 Protein FMP011, a Malaria Vaccine Candidate, Delivered with Adjuvant AS01B or AS02A
2006cited by this paper
Developmental Biology of Sporozoite-Host Interactions in Plasmodium falciparum Malaria: Implications for Vaccine Design
2006cited by this paper
Vaccines for preventing malaria (pre-erythrocytic).
2006cited by this paper
Enhancement of functional antibody responses to AMA1-C1/Alhydrogel, a Plasmodium falciparum malaria vaccine, with CpG oligodeoxynucleotide.
2006cited by this paper
Preclinical Evaluation of a Chimeric Malaria Vaccine Candidate in Montanide ISA 720®: Immunogenecity and Safety in Rhesus Macaques
2006cited by this paper
Infection with Plasmodium berghei Boosts Antibody Responses Primed by a DNA Vaccine Encoding Gametocyte Antigen Pbs48/45
2006cited by this paper
A Phase 2b Randomised Trial of the Candidate Malaria Vaccines FP9 ME-TRAP and MVA ME-TRAP among Children in Kenya
2006cited by this paper
Immunogenicity of the candidate malaria vaccines FP9 and modified vaccinia virus Ankara encoding the pre-erythrocytic antigen ME-TRAP in 1-6 year old children in a malaria endemic area.
2006cited by this paper
The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites
2006cited by this paper
Imidazolidin-4-one derivatives of primaquine as novel transmission-blocking antimalarials.
2005cited by this paper
Structural basis for the EBA-175 erythrocyte invasion pathway of the malaria parasite Plasmodium falciparum.
2005cited by this paper
Safety and Enhanced Immunogenicity of a Hepatitis B Core Particle Plasmodium falciparum Malaria Vaccine Formulated in Adjuvant Montanide ISA 720 in a Phase I Trial
2005cited by this paper
Immunization of Saimiri sciureus Monkeys with a Recombinant Hybrid Protein Derived from the Plasmodium falciparum Antigen Glutamate-Rich Protein and Merozoite Surface Protein 3 Can Induce Partial Protection with Freund and Montanide ISA720 Adjuvants
2005cited by this paper
Naturally acquired immunity to Plasmodium falciparum malaria in Africa.
2005cited by this paper
Academic Editor: Brian Greenwood, University of London, United Kingdom
2005cited by this paper
Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites.
2005cited by this paper
The Clinical-Grade 42-Kilodalton Fragment of Merozoite Surface Protein 1 of Plasmodium falciparum Strain FVO Expressed in Escherichia coli Protects Aotus nancymai against Challenge with Homologous Erythrocytic-Stage Parasites
2005cited by this paper
Convergent synthesis of a fully lipidated glycosylphosphatidylinositol anchor of Plasmodium falciparum.
2005cited by this paper
Effect of plasmid backbone modification by different human CpG motifs on the immunogenicity of DNA vaccine vectors
2005cited by this paper
Effect of adjuvant on reactogenicity and long-term immunogenicity of the malaria Vaccine ICC-1132 in macaques.
2005cited by this paper
Medicine: Knockout malaria vaccine?
2005cited by this paper
Process Development and Analysis of Liver-Stage Antigen 1, a Preerythrocyte-Stage Protein-Based Vaccine for Plasmodium falciparum
2005cited by this paper
T cell vaccines for microbial infections
2005cited by this paper
Innate immunity to malaria
2004cited by this paper
Fusion of Two Malaria Vaccine Candidate Antigens Enhances Product Yield, Immunogenicity, and Antibody-Mediated Inhibition of Parasite Growth In Vitro 1
2004cited by this paper
The global distribution and population at risk of malaria: past, present, and future.
2004cited by this paper
Antimalarial drug resistance.
2004cited by this paper
A Plasmodium falciparum GLURP-MSP3 chimeric protein; expression in Lactococcus lactis, immunogenicity and induction of biologically active antibodies.
2004cited by this paper
Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial.
2004cited by this paper
CPG 7909, an Immunostimulatory TLR9 Agonist Oligodeoxynucleotide, as Adjuvant to Engerix-B® HBV Vaccine in Healthy Adults: A Double-Blind Phase I/II Study
2004cited by this paper
Progress with new malaria vaccines.
2003cited by this paper
Heparan sulfate on endothelial cells mediates the binding of Plasmodium falciparum-infected erythrocytes via the DBL1alpha domain of PfEMP1.
2003cited by this paper
Discovery of Gene Function by Expression Profiling of the Malaria Parasite Life Cycle
2003cited by this paper
The Transcriptome of the Intraerythrocytic Developmental Cycle of Plasmodium falciparum
2003cited by this paper
Plasmodium falciparum apical membrane antigen 1 (PfAMA-1) is translocated within micronemes along subpellicular microtubules during merozoite development
2003cited by this paper
The cytoplasmic domain of the Plasmodium falciparum ligand EBA-175 is essential for invasion but not protein trafficking
2003cited by this paper
Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ1
2003cited by this paper
Structure of domain III of the blood-stage malaria vaccine candidate, Plasmodium falciparum apical membrane antigen 1 (AMA1).
2002cited by this paper
Rapid synthesis of a glycosylphosphatidylinositol-based malaria vaccine using automated solid-phase oligosaccharide synthesis.
2002cited by this paper
Synthetic GPI as a candidate anti-toxic vaccine in a model of malaria
2002cited by this paper
Malaria Vaccine: Candidate Antigens, Mechanisms, Constraints and Prospects
2002cited by this paper
Decoding the language of var genes and Plasmodium falciparum sequestration.
2001cited by this paper
Efficacy of RTS,S/AS02 malaria vaccine against Plasmodium falciparum infection in semi-immune adult men in The Gambia: a randomised trial.
2001cited by this paper
Antibodies against Merozoite Surface Protein (Msp)-119 Are a Major Component of the Invasion-Inhibitory Response in Individuals Immune to Malaria
2001cited by this paper
Antigenic variation at the infected red cell surface in malaria.
2001cited by this paper
Long synthetic peptides encompassing the Plasmodium falciparum LSA3 are the target of human B and T cells and are potent inducers of B helper, T helper and cytolytic T cell responses in mice
2001cited by this paper
Inhibitory and blocking monoclonal antibody epitopes on merozoite surface protein 1 of the malaria parasite Plasmodium falciparum.
2001cited by this paper
Candidacy of liver stage antigen-1 for Plasmodium falciparum vaccine development
2001cited by this paper
Analysis of Immune Responses against T- and B-Cell Epitopes fromPlasmodium falciparum Liver-Stage Antigen 1 in Rodent Malaria Models and Malaria-Exposed Human Subjects in India
2000cited by this paper
Cytotoxic T-Lymphocyte Epitopes for HLA-B53 and Other HLA Types in the Malaria Vaccine Candidate Liver-Stage Antigen 3
2000cited by this paper
Antibodies against the Plasmodium falciparum Receptor Binding Domain of EBA-175 Block Invasion Pathways That Do Not Involve Sialic Acids
2000cited by this paper
Plasmodium falciparum: analysis of the antibody specificity to the surface of the trophozoite-infected erythrocyte.
1999cited by this paper
Solution structure of an EGF module pair from the Plasmodium falciparum merozoite surface protein 1.
1999cited by this paper
Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria.
1999cited by this paper
Plasmodium falciparum malaria.
1999cited by this paper
Escalante AA, Lal AA, Ayala FJ. Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum. Genetics 149: 189-202
1998cited by this paper
Monocytes.
1998cited by this paper
Genetic polymorphism and natural selection in the malaria parasite Plasmodium falciparum.
1998cited by this paper
Cloning and cross-species comparison of the thrombospondin-related anonymous protein (TRAP) gene from Plasmodium knowlesi, Plasmodium vivax and Plasmodium gallinaceum.
1997cited by this paper
Cell invasion by the vertebrate stages of Plasmodium.
1997cited by this paper
A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group.
1997cited by this paper
Conservation of structural motifs and antigenic diversity in the Plasmodium falciparum merozoite surface protein-3 (MSP-3).
1997cited by this paper
The Disulfide Bond Structure of Plasmodium Apical Membrane Antigen-1*
1996cited by this paper
NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria
1996cited by this paper
Diversity of the vaccine candidate AMA-1 of Plasmodium falciparum.
1996cited by this paper

CITED BY

Immunological evaluation of two novel engineered Plasmodium vivax circumsporozoite proteins formulated with different human-compatible vaccine adjuvants in C57BL/6 mice
2019cites this paper
Antimalarial Activities of Moringa Oleifera Leaf Extract Against Plasmodium Berghei ANKA Infection in ICR Mice
2016cites this paper
Immuno-Informatic Prediction of Immuno - Genetic DNA Vaccine From Pfm18aapof "Plasmodium Falciparum"
2014cites this paper